Abstract 4693: Evaluation of prostate tumor molecular heterogeneity using whole mount radical prostatectomy by dual immunohistochemistry and dual RNA<i>in situ</i>hybridization
Pavithra D. Arachchige(Henry Ford Health System), Nallasivam Palanisamy(Henry Ford Health System), Gaury Dhamdhere(Henry Ford Health System), Craig Rogers(Norfolk and Norwich University Hospitals NHS Foundation Trust), Hans Stricker(University Hospital of Bern), James O. Peabody(Henry Ford Hospital), Nilesh Gupta(Henry Ford Health System), Mani Menon(Henry Ford Hospital), Sean R. Williamson(Cleveland Clinic), Shannon Carskadon(Henry Ford Health System), Mireya Diaz‐Insua
Cited by 0
Related Papers
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth
|JAMA|2015|420
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
|Clinical Cancer Research|2013|358